LC–MS/MS results showed a reduction in the protein levels of ABCA8, ABCB1, and ABCG2; hence, we examined whether sulbactam can inhibit the mRNA expression of ABC transporters in the human breast cancer cells in the presence of doxorubicin. This evidence concerns the gene ABCA8 and breast carcinoma.